CNS Pharmaceuticals, Inc.
CNSP
$6.66
$0.152.30%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/21/2025
-
TipRanks Financial Blog
11/18/2025
-
TipRanks Financial Blog
11/17/2025
-
SeekingAlpha
11/17/2025
-
Seeking Alpha: Transcripts
11/17/2025
-
GuruFocus
11/17/2025
-
GuruFocus
11/17/2025
-
The Fly
11/17/2025
-
The Fly
11/17/2025
-
ACCESS Newswire
11/10/2025
-
GuruFocus
11/10/2025
-
ACCESS Newswire
10/22/2025
-
TipRanks Financial Blog
9/17/2025
-
Ticker Report
9/13/2025
-
Yahoo! Finance: News
9/13/2025
-
Ticker Report
9/12/2025
-
The Fly
9/12/2025
-
The Fly
9/6/2025
-
Ticker Report
9/3/2025
-
GuruFocus
9/3/2025
-
ACCESS Newswire
8/27/2025
-
Globe Newswire
8/27/2025
-
Ticker Report
8/15/2025
-
GuruFocus
8/15/2025
-
ACCESS Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
800-946-9185
Address
2100 West Loop South
Houston, TX 77027
Houston, TX 77027
Country
Year Founded
Business Description
Sector
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company’s drug...
more